These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12142351)

  • 1. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
    Vecchione C; Brandes RP
    Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin.
    Christ M; Bauersachs J; Liebetrau C; Heck M; Günther A; Wehling M
    Diabetes; 2002 Aug; 51(8):2648-52. PubMed ID: 12145183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular antioxidant effects of atorvastatin in vitro and in vivo.
    Wassmann S; Laufs U; Müller K; Konkol C; Ahlbory K; Bäumer AT; Linz W; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):300-5. PubMed ID: 11834532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways.
    Bruder-Nascimento T; Callera GE; Montezano AC; He Y; Antunes TT; Nguyen Dinh Cat A; Tostes RC; Touyz RM
    Clin Sci (Lond); 2015 Apr; 128(7):411-23. PubMed ID: 25358739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
    Jung O; Schreiber JG; Geiger H; Pedrazzini T; Busse R; Brandes RP
    Circulation; 2004 Apr; 109(14):1795-801. PubMed ID: 15037533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits.
    Paravicini TM; Gulluyan LM; Dusting GJ; Drummond GR
    Circ Res; 2002 Jul; 91(1):54-61. PubMed ID: 12114322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy.
    Rueckschloss U; Galle J; Holtz J; Zerkowski HR; Morawietz H
    Circulation; 2001 Oct; 104(15):1767-72. PubMed ID: 11591612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Tanaka S; Fukumoto Y; Nochioka K; Minami T; Kudo S; Shiba N; Takai Y; Williams CL; Liao JK; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1591-600. PubMed ID: 23640485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex.
    de Oliveira CV; Funck VR; Pereira LM; Grigoletto J; Rambo LM; Ribeiro LR; Royes LF; Furian AF; Oliveira MS
    Pharmacol Res; 2013 May; 71():1-8. PubMed ID: 23428346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA; Huang Q; Tesfamariam B
    Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of action for statins against diabetes-induced oxidative stress.
    Vecchione C; Gentile MT; Aretini A; Marino G; Poulet R; Maffei A; Passarelli F; Landolfi A; Vasta A; Lembo G
    Diabetologia; 2007 Apr; 50(4):874-80. PubMed ID: 17279352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
    Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models.
    Cui W; Matsuno K; Iwata K; Ibi M; Katsuyama M; Kakehi T; Sasaki M; Ikami K; Zhu K; Yabe-Nishimura C
    J Pharmacol Sci; 2009 Nov; 111(3):260-8. PubMed ID: 19881226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells.
    Brandes RP; Beer S; Ha T; Busse R
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1794-800. PubMed ID: 12933532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.